SIBUR, following the resounding success of its medical-grade polymers within the Russian and CIS markets, has extended its offerings to a broader global clientele. Customers from China, Turkey, as well as various nations across Africa and the Middle East, are now presented with the opportunity to evaluate and utilize SIBUR's specialized medical-grade polyethylene and polypropylene. These polymers are tailor-made for applications such as infusion solution packaging and the production of medical devices.

One of SIBUR's standout offerings is their polyethylene, specifically designed for Blow-Fill-Seal (BFS) packaging used in the containment of infusion solutions. What sets SIBUR's product apart is its remarkable ability to withstand sterilization temperatures of up to 121 degrees Celsius. This is a significant advancement in comparison to the industry standard, which typically maxes out at 108 degrees Celsius. Such elevated temperature resistance ensures the safety and integrity of medical-grade packaging, an essential feature for the pharmaceutical industry and healthcare sector.

Furthermore, it's worth noting that SIBUR's medical-grade polyethylene and polypropylene have received strong endorsements from leading BFS machinery manufacturers. These polymers also adhere to the stringent standards set by European and US pharmacopoeias, further reinforcing their quality and reliability. The successful initial trials of SIBUR's medical-grade polymers in Egypt have demonstrated that they not only meet but exceed the specified characteristics required for packaging infusion solutions. Consequently, these polymers have received approval for use in such applications in Egypt. SIBUR is currently in active negotiations to establish regular supply agreements with multiple pharmaceutical producers in Egypt, underlining the growing demand for their high-quality medical-grade polymers.

In a move that highlights SIBUR's commitment to ensuring the global availability of their products, samples of their medical-grade polymers are presently undergoing rigorous testing in various countries. This includes China, Kenya, Saudi Arabia, and the United Arab Emirates, where experts are putting these materials through their paces to assess their suitability and performance.

SIBUR's decision to extend its medical-grade polymer offerings to international markets marks a strategic move, given the essential role of such materials in the healthcare and pharmaceutical industries. The heightened temperature resistance of their polyethylene for BFS packaging for infusion solutions is particularly noteworthy, offering a superior solution to an industry with stringent requirements. With endorsements from machinery manufacturers and alignment with global pharmacopoeias, SIBUR's products are poised to make a significant impact on the global medical packaging and device manufacturing landscape.

The successful trials in Egypt, leading to approval for regular supply to pharmaceutical producers, underscore the practicality and effectiveness of SIBUR's medical-grade polymers. As they continue to undergo testing in various nations, such as Asia, Africa, and the Middle East, SIBUR's commitment to global accessibility and reliability becomes increasingly evident. The results of these tests will drive greater demand for their products, benefiting healthcare systems worldwide by ensuring the availability of top-tier medical-grade polymers for critical applications.